Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer
Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer
Irinotecan And Carboplatin Improve Response In NSCLC
Enzastaurin Shows Activity In Recurrent High-Grade Glioma
Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer
Gemcitabine Improves DFS In Resected Pancreatic Cancer
Rosenberg: Immunotherapy May Have Broad Potential
NCI-Approved Clinical Trials
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In the Headlines: Missing record of NCAB meetings restored to NIH website
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”
